A change of heart from the US SEC may open the door for rapid growth of actively managed ETFs both in the US and Australia.
FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. After a long period with a negative or neutral position on Mayne Pharma, Wilsons has decided now is the time to buy.
Michael Gable of Fairmont Equities notes Kogan.com’s recovery appears set for a new phase.
Despite a soft top line in the March quarter, brokers are reasonably confident that jeweller Michael Hill has enough in the kitty to meet FY19 expectations.
Pitt Street Research has updated on DomaCom, ready to revolutionise property investing in Australia.
Consensus is that it’s not a matter of ‘if’ for coal’s decline but ‘when’. FNArena reviews a number of factors affecting the pace of the global transition. This is Part One.
Despite weak production outcomes in the March quarter, Carrapateena is expected to provide OZ Minerals with a positive catalyst when production starts later in the year.
A glance through the latest expert views and predictions about commodities. Energy; thermal coal; and Oz gold miners.
Craig Parker of Moat Capital suggests the ASX200 looks set to recover the previous high, election notwithstanding.
Bank of Queensland sustained no growth in its home loan book in the first half and its retail bank continues to struggle. Brokers suggest the absence of a permanent CEO has hindered development of a definitive strategy.
